Cumberland Pharmaceuticals (CPIX) Institutional Ownership $5.87 0.00 (0.00%) Closing price 05/22/2026 04:00 PM EasternExtended Trading$5.68 -0.19 (-3.24%) As of 05/22/2026 07:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Cumberland Pharmaceuticals (NASDAQ:CPIX)CurrentInstitutional OwnershipPercentage15.51%Number ofInstitutional Buyers(last 12 months)9TotalInstitutional Inflows(last 12 months)$1.91MNumber ofInstitutional Sellers(last 12 months)7TotalInstitutional Outflows(last 12 months)$1.70M Get CPIX Insider Trade Alerts Want to know when executives and insiders are buying or selling Cumberland Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Chart & View Institutional Buying and Selling Data CPIX Institutional Buying and Selling by Quarter Cumberland Pharmaceuticals Major Shareholders & Ownership History ExportReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/14/2026 Arrowstreet Capital Limited Partnership20,252$66K0.0%N/A0.135% 5/7/2026 Dimensional Fund Advisors LP276,359$898K0.0%+1.5%1.848% 5/5/2026 Bank of New York Mellon Corp58,458$190K0.0%-19.4%0.391% 2/18/2026 Perceptive Advisors LLC341,087$1.36M0.0%N/A2.280% 2/18/2026 Boothbay Fund Management LLC128,507$511K0.0%-23.6%0.859% 2/18/2026 Bridgeway Capital Management LLC163,468$651K0.0%-13.2%1.093% 2/17/2026 J. Goldman & Co LP94,541$376K0.0%-54.6%0.632% 2/13/2026 Marshall Wace LLP48,137$192K0.0%N/A0.322% 2/12/2026 Renaissance Technologies LLC472,163$1.88M0.0%-8.4%3.156% 2/12/2026 Dimensional Fund Advisors LP272,278$1.08M0.0%-3.1%1.820% Get the Latest News and Ratings for CPIX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cumberland Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 2/9/2026 Geode Capital Management LLC107,274$427K0.0%+5.6%0.717% 11/17/2025 Millennium Management LLC598,634$1.87M0.0%-22.9%4.002% 11/17/2025 Boothbay Fund Management LLC168,132$525K0.0%-6.7%1.124% 11/14/2025 Two Sigma Investments LP37,591$117K0.0%+16.5%0.251% 11/12/2025 Dimensional Fund Advisors LP280,869$876K0.0%+11.1%1.877% 8/15/2025 Boothbay Fund Management LLC180,229$604K0.0%-19.5%1.205% 8/15/2025 Bridgeway Capital Management LLC188,355$631K0.0%+2.3%1.259% 8/12/2025 XTX Topco Ltd10,280$34K0.0%N/A0.069% 8/12/2025 Heron Bay Capital Management33,251$111K0.0%N/A0.222% 5/21/2025Acadian Asset Management LLC49,137$207K0.0%-73.9%0.328% 5/16/2025Adage Capital Partners GP L.L.C.150,000$634K0.0%N/A1.074% 5/14/2025Walleye Capital LLC70,419$298K0.0%N/A0.504% 5/14/2025Berkshire Asset Management LLC PA153,810$692K0.0%N/A1.101% 5/13/2025Cresset Asset Management LLC19,975$84K0.0%-10.3%0.143% 5/13/2025Informed Momentum Co LLC71,776$304K0.1%N/A0.514% 4/29/2025Bank of New York Mellon Corp72,513$307K0.0%-3.7%0.519% 2/17/2025Two Sigma Investments LP37,649$89K0.0%+94.3%0.268% 2/17/2025Bridgeway Capital Management LLC184,155$436K0.0%-35.8%1.312% 2/14/2025Dimensional Fund Advisors LP272,969$647K0.0%-3.9%1.944% 2/13/2025Renaissance Technologies LLC507,163$1.20M0.0%-4.0%3.612% 8/9/2024Dimensional Fund Advisors LP304,109$465K0.0%-15.0%2.143% 10/24/2023Bank of New York Mellon Corp75,268$142K0.0%N/A0.524% 7/27/2023B. Riley Wealth Advisors Inc.90,298$133K0.0%N/A0.625% 2/10/2023True Capital Management12,025$27K0.0%N/A0.082% 5/24/2022M Holdings Securities Inc.10,750$30K0.0%N/A0.073% 2/9/2022Dimensional Fund Advisors LP652,561$3.05M0.0%-6.3%4.406% CPIX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of CPIX shares? During the previous two years, 20 institutional investors and hedge funds held shares of Cumberland Pharmaceuticals. The most heavily invested institutionals were Renaissance Technologies LLC ($1.88M), Millennium Management LLC ($1.87M), Perceptive Advisors LLC ($1.36M), Dimensional Fund Advisors LP ($898K), Berkshire Asset Management LLC PA ($692K), Bridgeway Capital Management LLC ($651K), and Adage Capital Partners GP L.L.C. ($634K).Learn more on Cumberland Pharmaceuticals' institutional investors. What percentage of Cumberland Pharmaceuticals' stock is owned by institutional investors? 15.51% of Cumberland Pharmaceuticals' stock is owned by institutional investors. Learn more on CPIX's institutional investor holdings. Which institutional investors have been buying Cumberland Pharmaceuticals' stock? Of the 13 institutional investors that purchased Cumberland Pharmaceuticals' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Perceptive Advisors LLC ($341.09K), Berkshire Asset Management LLC PA ($153.81K), Adage Capital Partners GP L.L.C. ($150K), Informed Momentum Co LLC ($71.78K), Walleye Capital LLC ($70.42K), Marshall Wace LLP ($48.14K), and Heron Bay Capital Management ($33.25K). How much institutional buying is happening at Cumberland Pharmaceuticals? Institutional investors have bought a total of 500,247 shares in the last 24 months. This purchase volume represents approximately $1.91M in transactions. Which of Cumberland Pharmaceuticals' major shareholders have been selling company stock? The following institutional investors have sold Cumberland Pharmaceuticals stock in the last 24 months: Millennium Management LLC ($177.34K), J. Goldman & Co LP ($113.60K), Boothbay Fund Management LLC ($95.29K), Renaissance Technologies LLC ($43.30K), Bridgeway Capital Management LLC ($24.89K), Bank of New York Mellon Corp ($14.06K), and Dimensional Fund Advisors LP ($8.59K). How much institutional selling is happening at Cumberland Pharmaceuticals? Institutional investors have sold a total of 477,070 shares in the last 24 months. This volume of shares sold represents approximately $1.70M in transactions. Related Companies LLY Major Shareholders JNJ Major Shareholders ABBV Major Shareholders MRK Major Shareholders PFE Major Shareholders BMY Major Shareholders ZTS Major Shareholders RPRX Major Shareholders JAZZ Major Shareholders CORT Major Shareholders This page (NASDAQ:CPIX) was last updated on 5/25/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredSpaceX IPO hides a much bigger storyThe SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...Weiss Ratings | SponsoredSpaceX will mint billionaires. You won't be one of them.By the time a company goes public, 95% of profits have already been made. Insiders bought SpaceX at $20 billio...Behind the Markets | SponsoredSatellite Images Spot Potential $10 Trillion Discovery'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...Altimetry | SponsoredSpaceX just filed. The clock is ticking.Reuters reports Elon Musk filed secretly. Barron's says it's being finalized behind closed doors. CNBC just re...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cumberland Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cumberland Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
